Atlas Trials

Long Term Safety Follow up of Haematopoietic Stem Cell Gene Therapy for the Wiskott Aldrich Syndrome

Clinical trial NCT02333760 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02333760
Sponsor
Genethon
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Wiskott-Aldrich Syndrome
Start date
2014-09-01
Primary completion
2032-10-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.